'1','agrA (RN27)','SA1844','g','stationary phase wild type expression is compared to the corresponding agrA mutant expression.','11717293','Custom-made Affymetrix GeneChip','GeneSpring','2','RN27','Duplicate','NONE',''
'2','sarA (RN27)','SA0573','g','stationary phase wild type expression is compared to the corresponding sarA mutant expression.','11717293','Custom-made Affymetrix GeneChip','GeneSpring','2','RN27','Duplicate','NONE',''
'3','rot','SA1583','g','late exponential phase parental strain (agr-) expression is compared to the corresponding rot double mutant (agr-/rot-) expression.','12511508','Custom-made Affymetrix GeneChip','GeneSpring','2','RN6390','Duplicate','NONE',''
'4','vraSR','SA1701','g','exponential (OD 0.6 at 660nm) phase wild type (N315) expression is compared to the corresponding vraSR mutant expression.','12864861','Custom spotted Microarray (ATG, Japan)','ImaGene','2','N315','Duplicate','NONE',''
'5','sigB','SA1869','g','late exponential phase (OD 2.0 at 600nm) wild type (COL, Newman, GP268) expression is compared to the respective sigB mutant expression.','15205410','Custom-made Affymetrix GeneChip','GeneSpring','2','COL','Duplicate','NONE',''
'6','tcaR','SA2147','g','late exponential phase (OD 2.0 at 600nm) wild type (COL) expression is compared to the corresponding tcaRAB mutant expression.','15126456','Custom-made Affymetrix GeneChip','GeneSpring','2','COL','Duplicate','NONE',''
'7','arlR','SA1247','g','mid exponential phase (OD 0.4 at 600nm) wild type (WCUH29) expression is compared to the corresponding arlR mutant expression.','16030243','Custom-made Affymetrix GeneChip','GeneSpring','1.8','WCUH29','Triplicate','NONE',''
'8','traP','SA1653','g','post exponential phase (from OD 600 of 0.03 for 6 hr) wild type 8325-4 expression is compared to the corresponding traP mutant expression.','16177293','S. aureus Affymetrix GeneChip','MAS 5.0','1','8325-4','NOT AVAILABLE','RNA Protect',''
'9','mgrA (OD 0.4)','SA0641','g','exponential phase (OD 0.4 at 660nm) wild type Newman expression is compared to the corresponding mgrA mutant expression.','16484201','S. aureus Affymetrix GeneChip','GeneSpring','2','Newman','Duplicate','NONE',''
'10','mgrA (OD 4.0)','SA0641','g','early stationary phase (OD 0.4 at 660nm) wild type Newman expression is compared to the corresponding mgrA mutant expression.','16484201','S. aureus Affymetrix GeneChip','GeneSpring','2','Newman','Duplicate','NONE',''
'11','cidR','SA2330','g','early stationary phase (6 h post inoculation) wild type (UAMS-1) expression is compared to the corresponding cidR mutant expression.','16573694','S. aureus Affymetrix GeneChip','GeneSpring','2','UAMS-1','Duplicate','NONE',''
'12','sarA (UAMS-1 OD 1.0)','SA0573','g','exponential phase (OD 1.0 at 560nm) wild type (UAMS-1) expression is compared to the corresponding sarA mutant expression.','17005987','S. aureus Affymetrix GeneChip','GeneSpring','3','UAMS-1','Duplicate','NONE','GEO:GSE5466'
'13','sarA (UAMS-1 OD 3.0)','SA0573','g','post exponential phase (OD 3.0 at 560nm) wild type (UAMS-1) expression is compared to the corresponding sarA mutant expression.','17005987','S. aureus Affymetrix GeneChip','GeneSpring','3','UAMS-1','Duplicate','NONE','GEO:GSE5466'
'14','agrA (UAMS-1 OD 1.0)','SA1844','g','exponential phase (OD 1.0 at 560nm) wild type (UAMS-1) expression is compared to the corresponding sarA mutant expression.','17005987','S. aureus Affymetrix GeneChip','GeneSpring','3','UAMS-1','Duplicate','NONE','GEO:GSE5466'
'15','agrA (UAMS-1 OD 3.0)','SA1844','g','post exponential phase (OD 3.0 at 560nm) wild type (UAMS-1) expression is compared to the corresponding sarA mutant expression.','17005987','S. aureus Affymetrix GeneChip','GeneSpring','3','UAMS-1','Duplicate','NONE','GEO:GSE5466'
'16','Peracetic Acid 10min','PeraceticAcid_10min','e','early exponential phase (OD 0.8 at 600nm) wild type (NCTC 8325) expression is compared to the 1mM peracetic acid treated (exposed for 10min) NCTC 8325 expression.','16955917','S. aureus Affymetrix GeneChip','GCOS','2','NCTC_8325','Triplicate','NONE','GEO:GSE4184'
'17','Peracetic Acid 20min','PeraceticAcid_20min','e','early exponential phase (OD 0.8 at 600nm) wild type (NCTC 8325) expression is compared to the 1mM peracetic acid treated (exposed for 20min) NCTC 8325 expression.','16955917','S. aureus Affymetrix GeneChip','GCOS','2','NCTC_8325','Triplicate','NONE','GEO:GSE4184'
'18','saeRS (N315)','SA0661','g','mid exponential phase wild type (N315) expression is compared to the corresponding saeRS mutant expression.','17263851','Custom spotted Microarray','ImaGene','2','N315','Duplicate','NONE',''
'19','Cold shock','ColdShock','e','mid exponential phase (OD 0.25 at 600nm) wild type (UAMS-1) expression is compared to the corresponding cold shocked (10 Degree C for 30min with aeration) UAMS-1 expression.','16980476','S. aureus Affymetrix GeneChip','GeneSpring','2','UAMS-1','Duplicate','NONE',''
'20','Heat shock','HeatShock','e','mid exponential phase (OD 0.25 at 600nm) wild type (UAMS-1) expression is compared to the corresponding cold shocked (42 Degree C for 30min with aeration) UAMS-1 expression.','16980476','S. aureus Affymetrix GeneChip','GeneSpring','2','UAMS-1','Duplicate','NONE',''
'21','Stringent response','StringentResponse','e','mid exponential phase (OD 0.25 at 600nm) wild type (UAMS-1) expression is compared to the corresponding Mupirocin treated (60ug/ml for 30min with with aeration) UAMS-1 expression.','16980476','S. aureus Affymetrix GeneChip','GeneSpring','2','UAMS-1','Duplicate','NONE',''
'22','SOS response','SOSResponse','e','mid exponential phase (OD 0.25 at 600nm) wild type (UAMS-1) expression is compared to the corresponding Mitomycin C treated (1ug/ml for 30min with with aeration) UAMS-1 expression.','16980476','S. aureus Affymetrix GeneChip','GeneSpring','2','UAMS-1','Duplicate','NONE',''
'23','clpP','SA0723','g','exponential (OD 1.0 at 600nm) phase wild type (NCTC 8325) expression is compared to the corresponding clpP mutant expression.','16885446','Spotted Microarray (Scienion, Germany)','Expressionist','2','NCTC_8325','Quadruplicate','RNA Protect',''
'24','Hydrogen Peroxide 10min','H2O2_10min','e','early exponential phase (OD 0.8 at 600nm) wild type (NCTC 8325) expression is compared to the Hydrogen Peroxide treated (10mM for 10min) NCTC 8325 expression.','16452450','S. aureus Affymetrix GeneChip','GCOS','2','NCTC_8325','Triplicate','NONE','GEO:GSE3415'
'25','Hydrogen Peroxide 20min','H2O2_20min','e','early exponential phase (OD 0.8 at 600nm) wild type (NCTC 8325) expression is compared to the Hydrogen Peroxide treated (10mM for 20min) NCTC 8325 expression.','16452450','S. aureus Affymetrix GeneChip','GCOS','2','NCTC_8325','Triplicate','NONE','GEO:GSE3415'
'26','Oxacillin','Oxacillin','e','early exponential (OD 0.3 at 600nm) phase wild type (8325-4) expression is compared to the Oxacillin treated (1.2ug/ml for 60min) 8325-4 expression.','14523105','S. aureus Affymetrix GeneChip','GeneSpring','2','8325-4','Duplicate','NONE',''
'27','D-Cycloserine','D_Cycloserine','e','early exponential (OD 0.3 at 600nm) phase wild type (8325-4) expression is compared to the D-Cycloserine treated (150ug/ml for 60min) 8325-4 expression.','14523105','S. aureus Affymetrix GeneChip','GeneSpring','2','8325-4','Duplicate','NONE',''
'28','Bacitracin','Bacitracin','e','early exponential (OD 0.3 at 600nm) phase wild type (8325-4) expression is compared to the Bacitracin treated (6.7units/ml for 60min) 8325-4 expression.','14523105','S. aureus Affymetrix GeneChip','GeneSpring','2','8325-4','Duplicate','NONE',''
'29','Mild Acid 0hr','MildAcid_0hr','e','expression of RN6734 grown at pH 5.5 is  compared to the expression of RN6734 grown at pH 7.5 for 0hr (T0) (density ~1.5 x 10^8 CFU/ml).','15576791','S. aureus Affymetrix GeneChip','GeneSpring','2','RN6734','Duplicate','RNA Protect',''
'30','Mild Acid 3hr','MildAcid_3hr','e','expression of RN6734 grown at pH 5.5 is  compared to the expression of RN6734 grown at pH 7.5, incubated for 3hr from T0 (T0=initial density ~1.5 x 10^8 CFU/ml).','15576791','S. aureus Affymetrix GeneChip','GeneSpring','2','RN6734','Duplicate','RNA Protect',''
'31','Mild Acid 6hr','MildAcid_6hr','e','expression of RN6734 grown at pH 5.5 is  compared to the expression of RN6734 grown at pH 7.5, incubated for 6hr from T0 (T0=initial density ~1.5 x 10^8 CFU/ml).','15576791','S. aureus Affymetrix GeneChip','GeneSpring','2','RN6734','Duplicate','RNA Protect',''
'32','Biofilm Vs Planktonic 6hr','BfilmVsPlank_6hr','e','biofilm grown (for 6hrs) SA113 expression is compared to the planktonically grown (for 6hrs) SA113 expression.','15870358','Spotted Microarray (Scienion, Germany)','Acuity','2.5','SA113','Quadruplicate','RNA Protect',''
'33','Biofilm Vs Planktonic 8hr','BfilmVsPlank_8hr','e','biofilm grown (for 8hrs) SA113 expression is compared to the planktonically grown (for 8hrs) SA113 expression.','15870358','Spotted Microarray (Scienion, Germany)','Acuity','2.5','SA113','Quadruplicate','RNA Protect',''
'34','Biofilm Vs Planktonic 16hr','BfilmVsPlank_16hr','e','biofilm grown (for 16hrs) SA113 expression is compared to the planktonically grown (for 16hrs) SA113 expression.','15870358','Spotted Microarray (Scienion, Germany)','Acuity','2.5','SA113','Quadruplicate','RNA Protect',''
'35','Biofilm Vs Planktonic 24hr','BfilmVsPlank_24hr','e','biofilm grown (for 24hrs) SA113 expression is compared to the planktonically grown (for 24hrs) SA113 expression.','15870358','Spotted Microarray (Scienion, Germany)','Acuity','2.5','SA113','Quadruplicate','RNA Protect',''
'36','Biofilm Vs Planktonic 48hr','BfilmVsPlank_48hr','e','biofilm grown (for 48hrs) SA113 expression is compared to the planktonically grown (for 48hrs) SA113 expression.','15870358','Spotted Microarray (Scienion, Germany)','Acuity','2.5','SA113','Quadruplicate','RNA Protect',''
'37','Salicylate','Salicylate','e','mid-exponential phase (OD 0.7 at 600nm) wild type (SH1000) expression is compared to Sodium Salicylate (2mM for 1hr) treated SH1000 expression.','17056754','TIGR-PFGRC S. aureus DNA Microarrays Version 2','TIGR-MIDAS','1.5','SH1000','Duplicate','RNA Protect, Trizol',''
'38','murF (suboptimal)','SA1886','g','expression of the murF conditional mutant grown under optimal IPTG (100uM) to the mid exponential (OD 0.7 at 620nm) phase is compared to the expression of the murF conditional mutant grown under sub-optimal IPTG (2.5uM) to the mid exponential phase.','17194794','S. aureus Affymetrix GeneChip','Spotfire DecisionSite','1.5','COL','Triplicate','RNA Protect',''
'39','Biofilm Vs Planktonic OD 1.0','BfilmVsPlank_OD1.0','e','UAMS-1 biofilm expression (one week old, grown in flow cell) is compared to mid exponential (OD 1.0 at 560nm) phase planktonic UAMS-1 expression.','15231800','S. aureus Affymetrix GeneChip','GeneSpring','2','UAMS-1','Duplicate','Ice-Cold Ethanol:Acetate',''
'40','Biofilm Vs Planktonic OD 3.5','BfilmVsPlank_OD3.5','e','UAMS-1 biofilm expression (one week old, grown in flow cell) is compared to stationary (OD 3.5 at 560nm) phase planktonic UAMS-1 expression.','15231800','S. aureus Affymetrix GeneChip','GeneSpring','2','UAMS-1','Duplicate','Ice-Cold Ethanol:Acetate',''
'41','Nitrosative stress','NitrosativeStress','e','mid exponential (OD 0.5 at 660nm) phase, S-nitroso N-acetyl-D,L-penicillamine (SNAP) treated COL expression is compared to the corresponding N-acetyl-D,L-penicillamine (NAP) treated COL expression.','16859493','S. aureus Affymetrix GeneChip','GeneSpring','1.5','COL','Duplicate','Ice-Cold Ethanol-Ace','http://www.blackwell-synergy.com/doi/suppl/10.1111/j.1365-2958.2006.05290.x/suppl_file/MMI5290TableS2.pdf'
'42','VISA Vs VSSA (Mu50 Vs N315)','VisaVsVssa_mu50VsN315','e','exponential (OD at 578nm) phase vancomycin-intermediate Mu50 expression is compared to the exponential phase vancomycin-susceptible N315 expression.','16048954','Custome made spotted array','ImaGene','2','N315-clonotype','Duplicate','NONE',''
'43','VISA Vs VSSA (Mu50 Vs Mu50-P)','VisaVsVssa_mu50VsMu50-P','e','exponential (OD at 578nm) phase vancomycin-intermediate Mu50 expression is compared to the expression of its vancomycin-susceptible isogenic derivative Mu50-P.','16048954','Custome made spotted array','ImaGene','2','N315-clonotype','Duplicate','NONE',''
'44','VISA Vs VSSA (Mu50-PR Vs Mu50-P)','VisaVsVssa_mu50-PRVsMu50-P','e','exponential (OD at 578nm) phase vancomycin-intermediate Mu50-PR (revertant) expression is compared to the exponential phase vancomycin-susceptible Mu50-P (derivative of Mu50) expression.','16048954','Custome made spotted array','ImaGene','2','N315-clonotype','Duplicate','NONE',''
'45','VISA Vs VSSA (MI Vs MI-P)','VisaVsVssa_miVsmi-P','e','exponential (OD at 578nm) phase vancomycin-intermediate strain MI expression is compared to the expression of its isogenic vancomycin-susceptible derivative (MI-P).','16048954','Custome made spotted array','ImaGene','2','N315-clonotype','Duplicate','NONE',''
'46','VISA Vs VSSA (MI-PR Vs MI-P)','VisaVsVssa_mi-PRVsmi-P','e','exponential (OD at 578nm) phase vancomycin-intermediate MI-PR (revertant) expression is compared to the exponential phase vancomycin-susceptible MI-P (derivative of MI) expression.','16048954','Custome made spotted array','ImaGene','2','N315-clonotype','Duplicate','NONE',''
'47','VISA Vs h-VISA (Mu50 Vs Mu3)','VisaVsVssa_mu50Vsmu3','e','exponential (OD at 578nm) phase vancomycin-intermediate Mu50 expression is compared to the exponential phase hetero-vancomycin-intermediate Mu3 expression.','16048954','Custome made spotted array','ImaGene','2','N315-clonotype','Duplicate','NONE',''
'48','Teicoplanin resistance','TeicoplaninResistance','e','late exponential phase (grown at 37C for 5hrs without shaking) expression of the teicoplanin-susceptible strain MRGR3 is compared to the expression of teicoplanin-resistant strain 14-4 expression. ','16940101','StaphChip oligoarray from Agilent','','1.5','MRGR3','Triplicate','Ice-Cold Ethanol-Acetate','ArrayExpress:E-MEXP-738'
'49','Glycopeptide resistance (14-4 Vs MRGR3)','GlycopepResis_14-4VsMRGR3','e','expression of stationary phase (OD 6 at 540nm) glycopeptide-intermediate strain 14-4 is compared to the expression of glycopeptide-susceptible strain MRGR3.','17121677','Custom made oligoarray from Agilent','GeneSpring','2','MRGR3','Triplicate','NONE','GEO:GSE5188'
'50','Glycopeptide resistance (14-4 Vs 14-4Rev)','GlycopepResis_14-4Vs14-4Rev','e','expression of stationary phase (OD 6 at 540nm) glycopeptide-intermediate strain 14-4 is compared to the expression of glycopeptide-susceptible 14-4Rev (revertant of 14-4).','17121677','Custom made oligoarray from Agilent','GeneSpring','2','MRGR3','Triplicate','NONE','GEO:GSE5188'
'51','Vancomycin resistance (HIP5827)','VancoResist_HIP5827','e','expression of mid exponential phase vancomycin-intermediate strain HIP5827 is compared to its highly vancomycin-resistant derivative VP-32 expression. ','12867477','TIGR-PFGRC S. aureus DNA Microarray','TIGR-MIDAS','1.5','HIP5827','Triplicate','NONE',''
'52','Vancomycin resistance (Mu50)','VancoResist_mu50','e','expression of mid exponential phase vancomycin-intermediate strain Mu50 is compared to its highly vancomycin-resistant derivative Mu50-32 expression. ','12867477','TIGR-PFGRC S. aureus DNA Microarray','TIGR-MIDAS','1.5','Mu50','Triplicate','NONE',''
'53','Vancomycin resistance (Newman)','VancoResist_Newman','e','expression of wild type strain (Newman) (grown to OD 2.0 at 600nm) is compared to the expression of vancomycin treated (10ug/ml for 5min at OD 2.0) Newman.','16891058','S. aureus Affymetrix GeneChip','','3','Newman','Duplicate','NONE',''
'54','Vancomycin resistance (JH1)','VancoResist_JH1','e','expression of exponential phase (OD 0.4 at 620nm) vancomycin-susceptible parent strain JH1 is compared to the expression of the vancomycin-susceptible JH1 grown in presence of vancomycin (8ug/ml for 30min).','16428416','S. aureus Affymetrix GeneChip','GeneSpring','2','JH1','Duplicate','RNA Protect',''
'55','VRSA Vs VSSA (JH9 Vs JH1)','VrsaVsVssa_JH9VsJH1','e','expression of exponential phase (OD 0.4 at 620nm) vancomycin-resistant strain JH9 is compared to the expression of vancomycin-susceptible strain JH1.','16428416','S. aureus Affymetrix GeneChip','GeneSpring','2','JH1','Duplicate','RNA Protect',''
'56','VRSA Vs VRSA (JH9 Vs JH14)','VrsaVsVrsa_JH9VsJH14','e','expression of exponential phase (OD 0.4 at 620nm) vancomycin-resistant strain JH9 (blood isolate) is compared to the expression of vancomycin-resistant strain JH14 (heart valve isolate).','16428416','S. aureus Affymetrix GeneChip','GeneSpring','2','JH1','Duplicate','RNA Protect',''
'57','Biofilm Vs Planktonic (early)','BfilmVsPlank_early','e','expression of early exponential phase (2h) planktonic culture is compared to expression of early (8h) biofilm culture. ','16714572','TIGR-PFGRC S. aureus DNA Microarray','TIGR-MIDAS','1.5','MRSA-M2','Triplicate','RNAlater',''
'58','Biofilm Vs Planktonic (maturing)','BfilmVsPlank_maturing','e','expression of late exponential phase (6h) planktonic culture is compared to expression of maturing (48h) biofilm culture.','16714572','TIGR-PFGRC S. aureus DNA Microarray','TIGR-MIDAS','1.5','MRSA-M2','Triplicate','RNAlater',''
'59','Biofilm Vs Planktonic (mature)','BfilmVsPlank_mature','e','expression of stationary phase (48h) planktonic culture is compared to expression of fully mature (336h) biofilm culture. ','16714572','TIGR-PFGRC S. aureus DNA Microarray','TIGR-MIDAS','1.5','MRSA-M2','Triplicate','RNAlater',''
'60','Vancomycin (N315)','Vanco_N315','e','exponential (OD 0.6 at 660nm) phase N315 wild type expression is compared to the vancomycin exposed N315 wild type expression (10ug/ml of vancomycin for 10 min).','12864861','Custom spotted Microarray (ATG, Japan)','ImaGene','2','N315','Duplicate','NONE',''
'61','Vancomycin (N315-VraSRmutant)','Vanco_N315VsVraSRmutant','e','exponential (OD 0.6 at 660nm) phase vraSR mutant expression is compared to the vancomycin exposed vraSR mutant expression (10ug/ml of vancomycin for 10 min).','12864861','Custom spotted Microarray (ATG, Japan)','ImaGene','2','N315','Duplicate','NONE',''
'62','Cefoxitin (N315)','Cefoxitin_N315','e','mid exponential phase wild type (N315) expression is compared to the Cefoxitin treated (8ug/ml for 10min) N315 expression.','17263851','Custom spotted Microarray','ImaGene','2','N315','Duplicate','NONE',''
'63','Cefoxitin (N315-SaeRSmutant)','Cefoxitin_N315VsSaeRSmutant','e','mid exponential phase N315-saeRS mutant expression is compared to the Cefoxitin treated (8ug/ml for 10min) N315-saeRS mutant expression.','17263851','Custom spotted Microarray','ImaGene','2','N315','Duplicate','NONE',''
'64','saeRS (COL OD 1.0)','SA0661','g','expression of wild type (COL) (OD 1.0 at 540nm) is compared to the expression of saeS mutant of COL. ','17079681','sciTRACER S. aureus N315 full genome microarray (Scienion, Germany)','Limma','2.5','COL','NOT AVAILABLE','NONE',''
'65','saeRS (COL OD 6.0)','SA0661','g','expression of wild type (COL) (OD 6.0 at 540nm) is compared to the expression of saeS mutant of COL. ','17079681','sciTRACER S. aureus N315 full genome microarray (Scienion, Germany)','Limma','2.5','COL','NOT AVAILABLE','NONE',''
'66','saeRS (Newman OD 1.0)','SA0661','g','expression of wild type (Newman) (OD 1.0 at 540nm) is compared to the expression of saeS mutant of Newman. ','17079681','sciTRACER S. aureus N315 full genome microarray (Scienion, Germany)','Limma','2.5','Newman','NOT AVAILABLE','NONE',''
'67','saeRS (Newman OD 6.0)','SA0661','g','expression of wild type (Newman) (OD 6.0 at 540nm) is compared to the expression of saeS mutant of Newman. ','17079681','sciTRACER S. aureus N315 full genome microarray (Scienion, Germany)','Limma','2.5','Newman','NOT AVAILABLE','NONE',''
'68','graRS','SA0615','g','expression of mid exponential phase (4h) wild type (SA113) is compared to the expression of graRS mutant of SA113.','17676995','Spotted Microarray (Scienion, Germany)','','2','SA113','Quadruplicate','RNA Protect',''
'69','Ciprofloxacin (30min)','Ciprofloxacin_30min','e','expression of wild type strain (8325) at early exponential phase (OD 0.5-0.6 at 600nm) is compared to that of the corresponding expression of the ciprofloxacin treated 8325 (0.8ug/ml for 30min).','17085555','TIGR-PFGRC S. aureus DNA Microarray','TIGR-MIDAS','2','NCTC_8325','Triplicate','RNA Protect','GEO:GSE6258'
'70','Ciprofloxacin (120min)','Ciprofloxacin_120min','e','expression of wild type strain (8325) at early exponential phase (OD 0.5-0.6 at 600nm) is compared to that of the corresponding expression of the ciprofloxacin treated 8325 (0.8ug/ml for 120min).','17085555','TIGR-PFGRC S. aureus DNA Microarray','TIGR-MIDAS','2','NCTC_8325','Triplicate','RNA Protect','GEO:GSE6258'
'71','lexA (ciprofloxacin 30min)','SA1174','g','expression of ciprofloxacin treated (0.8ug/ml for 30min) wild type strain (8325) at early exponential phase (OD 0.5-0.6 at 600nm) is compared to that of the corresponding expression of the ciprofloxacin treated (0.8ug/ml for 30min) lexA mutant of 8325 .','17085555','TIGR-PFGRC S. aureus DNA Microarray','TIGR-MIDAS','2','NCTC_8325','Triplicate','RNA Protect','GEO:GSE6258'
'72','lexA (ciprofloxacin 120min)','SA1174','g','expression of ciprofloxacin treated (0.8ug/ml for 30min) wild type strain (8325) at early exponential phase (OD 0.5-0.6 at 600nm) is compared to that of the corresponding expression of the ciprofloxacin treated (0.8ug/ml for 30min) lexA mutant of 8325 .','17085555','TIGR-PFGRC S. aureus DNA Microarray','TIGR-MIDAS','2','NCTC_8325','Triplicate','RNA Protect','GEO:GSE6258'
'73','Acid-shock (2min)','AcidShock_2min','e','expression of wild type strain (50583) at exponential phase (OD 1.0 at 600nm) is compared to the corresponding acid-shocked (450-500ul of 6.5M HCl for 2min) expression of 50583.','17600073','TIGR-PFGRC S. aureus DNA Microarray','GeneSpring','','50583','Triplicate','RNA Protect','GEO:GSE7273'
'74','Acid-shock (5min)','AcidShock_5min','e','expression of wild type strain (50583) at exponential phase (OD 1.0 at 600nm) is compared to the corresponding acid-shocked (450-500ul of 6.5M HCl for 5min) expression of 50583.','17600073','TIGR-PFGRC S. aureus DNA Microarray','GeneSpring','','50583','Triplicate','RNA Protect','GEO:GSE7273'
'75','Acid-shock (10min)','AcidShock_10min','e','expression of wild type strain (50583) at exponential phase (OD 1.0 at 600nm) is compared to the corresponding acid-shocked (450-500ul of 6.5M HCl for 10min) expression of 50583.','17600073','TIGR-PFGRC S. aureus DNA Microarray','GeneSpring','','50583','Triplicate','RNA Protect','GEO:GSE7273'
'76','Acid-shock (20min)','AcidShock_20min','e','expression of wild type strain (50583) at exponential phase (OD 1.0 at 600nm) is compared to the corresponding acid-shocked (450-500ul of 6.5M HCl for 20min) expression of 50583.','17600073','TIGR-PFGRC S. aureus DNA Microarray','GeneSpring','','50583','Triplicate','RNA Protect','GEO:GSE7273'
'77','Anaerobic (10min)','Anaerobic_10min','e','expression of aerobically grown cells (OD 0.5 at 500nm) is compared to the expression of anaerobically grown cells (10 min exposure to anaerobic condition).','17384184','sciTRACER S. aureus N315 full genome microarray (Scienion, Germany)','ArrayInformatics','2','COL','Duplicate','NONE','NOT AVAILABLE'
'78','Anaerobic (20min)','Anaerobic_20min','e','expression of aerobically grown cells (OD 0.5 at 500nm) is compared to the expression of anaerobically grown cells (20 min exposure to anaerobic condition).','17384184','sciTRACER S. aureus N315 full genome microarray (Scienion, Germany)','ArrayInformatics','2','COL','Duplicate','NONE','NOT AVAILABLE'
'79','Anaerobic (30min)','Anaerobic_30min','e','expression of aerobically grown cells (OD 0.5 at 500nm) is compared to the expression of anaerobically grown cells (30 min exposure to anaerobic condition).','17384184','sciTRACER S. aureus N315 full genome microarray (Scienion, Germany)','ArrayInformatics','2','COL','Duplicate','NONE','NOT AVAILABLE'
'80','Anaerobic (60min)','Anaerobic_60min','e','expression of aerobically grown cells (OD 0.5 at 500nm) is compared to the expression of anaerobically grown cells (60 min exposure to anaerobic condition).','17384184','sciTRACER S. aureus N315 full genome microarray (Scienion, Germany)','ArrayInformatics','2','COL','Duplicate','NONE','NOT AVAILABLE'
'81','hemB (lag)','SA1492','g','Wild type (strain A222231) expression is compared with hemB isogenic mutant expression at lag phase of growth.','16980462','Spotted Microarray (Scienion, Germany)','Expressionist','2','A222231','Triplicate','RNAprotect','NOT AVAILABLE'
'82','hemB (early-expo)','SA1492','g','Wild type (strain A222231) expression is compared with hemB isogenic mutant expression at early-exponential phase of growth.','16980462','Spotted Microarray (Scienion, Germany)','Expressionist','2','A222231','Triplicate','RNAprotect','NOT AVAILABLE'
'83','hemB (mid-expo)','SA1492','g','Wild type (strain A222231) expression is compared with hemB isogenic mutant expression at mid-exponential phase of growth.','16980462','Spotted Microarray (Scienion, Germany)','Expressionist','2','A222231','Triplicate','RNAprotect','NOT AVAILABLE'
'84','hemB (late-expo)','SA1492','g','Wild type (strain A222231) expression is compared with hemB isogenic mutant expression at late-exponential phase of growth.','16980462','Spotted Microarray (Scienion, Germany)','Expressionist','2','A222231','Triplicate','RNAprotect','NOT AVAILABLE'
'85','hemB (stationary)','SA1492','g','Wild type (strain A222231) expression is compared with hemB isogenic mutant expression at stationary phase of growth.','16980462','Spotted Microarray (Scienion, Germany)','Expressionist','2','A222231','Triplicate','RNAprotect','NOT AVAILABLE'
'86','Nitrite Stress','Nitrite','e','expression of SA113 cells grown in biofilm conditions (for 6hrs)is compared to the expression of SA113 grown in similar conditions but in presence of 5mM Sodium Nitrite.','17720780','Spotted Microarray (Scienion, Germany)','Acuity','2','SA113','Quadruplicate','',''
'87','Chlorination (10 min)','Chlorination_10min','e','mid exponential phase (OD 0.8 at 600nm) wild type (NCTC 8325) expression is compared to the 2.4mM Sodium Hypochlorite treated (exposed for 10min) NCTC 8325 expression.','18044543','S. aureus Affymetrix GeneChip','GCOS','2','NCTC_8325','Triplicate','NONE','GEO:GSE5498'
'88','Chlorination (20 min)','Chlorination_20min','e','mid exponential phase (OD 0.8 at 600nm) wild type (NCTC 8325) expression is compared to the 2.4mM Sodium Hypochlorite treated (exposed for 20min) NCTC 8325 expression.','18044543','S. aureus Affymetrix GeneChip','GCOS','2','NCTC_8325','Triplicate','NONE','GEO:GSE5498'
'89','Berberine Chloride','Berberine_chloride','e','early exponential phase (OD 0.3 at 600nm) wild type (ATCC25923) expression is compared to the 64 ug/ml berberine chloride treated (exposed for 45min) ATCC25923 expression.','18179590','S. aureus Affymetrix GeneChip','GCOS','2','ATCC25923','Triplicate','RNA Protect','GEO:GSE7944'
'90','femAB+backcross','femAB+backcross','g','Expression of wild type strain BB270 (NCTC8325 derivative) is compared to the expression of its isogenic femAB+backcross, at OD 0.8-1.0(600nm). ','17784943','Spotted Microarray (Scienion, Germany)','BioConductor','2','NCTC_8325','Triplicate','RNAProtect',''
'91','Triclosan (0.05uM, 10Min)','Triclosan_0_05uM_10Min','e','expression of wild type NCTC8325 strain is compared to the expression of NCTC8325 strain exposed to 0.05uM of Triclosan for 10 minutes.','18210102','S. aureus GeneChip (Affymetrix)','GeneSpring','2','NCTC_8325','Five replicates','','GEO:GSE8861'
'92','Triclosan (0.05uM, 60Min)','Triclosan_0_05uM_60Min','e','expression of wild type NCTC8325 strain is compared to the expression of NCTC8325 strain exposed to 0.05uM of Triclosan for 60 minutes.','18210102','S. aureus GeneChip (Affymetrix)','GeneSpring','2','NCTC_8325','Five replicates','','GEO:GSE8861'
'93','sarA (COL)','SA0573','g','post-exponential phase (OD4.0 at 560nm) wild type expression is compared to the corresponding sarA mutant expression.','19459979','TIGR-PFGRC','Acuity','3','COL','Duplicate','RNAProtect',''
'96','Fusidic acid stimulon','FusidicAcid','e','expression of SH1000 grown to OD 1.0 (580nm) and induced with 2mg/L fusidic acid for 15min was compared to the expression of the untreated SH1000.','18786940','TIGR-PFGRC S. aureus DNA Microarrays Version 4','TIGR-MIDAS','2','SH1000','Duplicate','RNA Protect, Trizol','GEO:GSE12210'
'97','Daptomycin (ATCC 29213)','Daptomycin_ATCC29213','e','expression of ATCC 29213 grown to OD 0.4 (600nm) and induced with 4ug/ml daptomycin for 15min was compared to the expression of the untreated ATCC 29213.','18086846','TIGR-PFGRC S. aureus DNA Microarrays Version 2','TIGR-MIDAS, SAM','2','ATCC 29213','Duplicate','RNA Protect, Trizon','GEO:GSE9494'
'98','Vancomycin (ATCC 29213)','Vancomycin_ATCC29213','e','expression of ATCC 29213 grown to OD 0.4 (600nm) and induced with 10ug/ml vancomycin for 15min was compared to the expression of the untreated ATCC 29213.','18086846','TIGR-PFGRC S. aureus DNA Microarrays Version 2','TIGR-MIDAS, SAM','2','ATCC 29213','Duplicate','RNA Protect, Trizon','GEO:GSE9494'
'99','CCCP (ATCC 29213)','CCCP_ATCC29213','e','expression of ATCC 29213 grown to OD 0.4 (600nm) and induced with 2ug/ml carbonyl cyanide m-chlorophenylhydrazone (CCCP)for 15min was compared to the expression of the untreated ATCC 29213.','18086846','TIGR-PFGRC S. aureus DNA Microarrays Version 2','TIGR-MIDAS, SAM','2','ATCC 29213','Duplicate','RNA Protect, Trizon','GEO:GSE9494'
'100','Nisin (ATCC 29213)','Nisin_ATCC29213','e','expression of ATCC 29213 grown to OD 0.4 (600nm) and induced with 20ug/ml nisin for 15min was compared to the expression of the untreated ATCC 29213.','18086846','TIGR-PFGRC S. aureus DNA Microarrays Version 2','TIGR-MIDAS, SAM','2','ATCC 29213','Duplicate','RNA Protect, Trizon','GEO:GSE9494'
'101','Oxacillin (SH1000)','Oxacillin_SH1000','e','expression of SH1000 grown to OD 0.4 (600nm) and induced with 1.2ug/ml oxacillin for 15min was compared to the expression of the untreated SH1000.','18086846','TIGR-PFGRC S. aureus DNA Microarrays Version 2','TIGR-MIDAS, SAM','2','SH1000','Duplicate','RNA Protect, Trizon','GEO:GSE9494'